Drug Channels Institute (DCI) is a leading provider of specialized management education and computer-based training for and about the pharmaceutical industry. >


DCI delivers educational solutions for clients that enhance the business acumen of employees, from senior executives to field reps to internal operations. State-of-the-art instructional design, coupled with extensive industry knowledge, allows DCI to build rigorous programs with accurate, fact-based content reflecting the latest developments. Even better, we deliver the material in an engaging, accessible manner using turn-key technology solutions. View a sample of our modules

View Sample

Industry Reports

The 2017 Economic Report on U.S. Pharmacies and Pharmacy Benefit Managers

This completely updated, revised, and expanded analysis of the $360+ billion U.S. pharmacy industry thoroughly dissects its interactions with the U.S. healthcare system. more >

The 2017-18 Economic Report on Pharmaceutical Wholesalers and Specialty Distributors

The most comprehensive tool for analyzing the economic and business realities of $425 billion U.S. pharmaceutical distribution industry. more >

From The Drug Channels Blog

Remicade: A Case Study in How U.S. Pricing and Reimbursement Curb Adoption of Biosimilars

The Centers for Medicare & Medicaid Services (CMS) has just released the Average Sales Prices (ASP) reimbursement data for the fourth quarter of 2017. You can download the drug pricing more >

Life Sciences 2nd Annual Value-Based Contracting Summit

Life Sciences 2nd Annual Value-Based Contracting SummitOctober 23-24, 2017 | Alexandria, VAwww.worldcongress.com/valuebasedThe Life Sciences 2nd Annual Value-Based Contracting Summit brings together key stakeholders to examine risk sharing strategies to overcome more >